LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) Finite-Lived Intangible Asset, Expected Amortization, after Year Five

LIGAND PHARMACEUTICALS INCORPORATED Finite-Lived Intangible Asset, Expected Amortization, after Year Five

LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) had Finite-Lived Intangible Asset, Expected Amortization, after Year Five of $2.40 million as of 2015-12-31, per its 10-K filed 2016-11-14.

Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive · last filed 2016-11-14

• 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $2.40M.